Skip to main content
4492 Results
 
msf-placeholder
Burundi

Thousands of Rwandan refugees living in precarious conditions

MSF is concerned about the unacceptable living conditions of Rwandan refugees regrouped in the Songore transit camp. Press Release - 1 Jun 2005
 
msf-placeholder
Indonesia

MSF fights malaria outbreak on islands in Indonesia

"If we manage to successfully limit the infestation by mosquitoes and give prompt and effective treatment to the sick, we can literally help the community get back on their feet." - MSF doctor Project Update - 13 May 2005
 
msf-placeholder
India

The future of generic medicines made in India

Prognosis: Short-term relief, long-term pain. The long-term impact of the Indian Patent Act is bad news for those relying on affordable new medicines - in MSF's own HIV/AIDS projects, for instance, approximately 70% of all patients currently take generic ARV medicines made in India. Worldwide, an estimated 350,000 people on ARV treatment depend on Indian generic production - that's half of all those on ARVs in developing countries. Project Update - 21 Apr 2005
 
msf-placeholder
Tuberculosis

World TB Day 2005: Development of simple and rapid diagnostic tools key for fighting tuberculosis

MSF is committed to participating to the development of new tests by assessing the feasibility of new technology in our field projects. Press Release - 15 Apr 2005
 
msf-placeholder
Sudan

MSF condemns violence in Darfur

Over the past year, MSF has systematically denounced the massive campaign of violence directed at civilians in Darfur led by pro-government 'Janjaweed' militia and Sudanese army units. Statement - 8 Apr 2005
 
msf-placeholder
Natural hazards

Asian tsunami: Three months financial overview

In an extraordinary demonstration of public support, MSF offices worldwide saw an unprecedented surge of spontaneous donations. Project Update - 8 Apr 2005
 
msf-placeholder
Global health

The beginning of the end of affordable generics

People who rely on low-cost medicines will have to wait three years before a generic company can even make an application for a right to produce the drug. Whereas people in wealthy countries will have access to new medicines immediately when they are proved safe and effective, people in poor countries will have to wait years. Press Release - 22 Mar 2005
 
msf-placeholder
Guatemala

New Guatemalan law and intellectual property provisions in DR-CAFTA threaten access to affordable medicines

The majority of patients in MSF's treatment programmes are prescribed generic ARVs, whereas Guatemala's social security system has spent 20 times more for some originator drugs. Press Release - 11 Mar 2005
 
msf-placeholder
Natural hazards

Asian tsunami: Overview of MSF activities in Sri Lanka

Overview of MSF activities in Sri Lanka. Project Update - 31 Jan 2005
 
msf-placeholder
Indonesia

Overview of MSF Activities in Indonesia

Project Update - 31 Jan 2005
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more